June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Paraoxonase-1 (PON1) in retinal physiology and pathophysiology
Author Affiliations & Notes
  • Jadwiga Oczos
    Lab for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, Zurich, Switzerland
    Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland
  • Barbara Kloeckener-Gruissem
    Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland
    Department of Biology, ETH Zurich, Zurich, Switzerland
  • Wolfgang Berger
    Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland
    Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland
  • Christian Grimm
    Lab for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, Zurich, Switzerland
    Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland
  • Footnotes
    Commercial Relationships Jadwiga Oczos, None; Barbara Kloeckener-Gruissem, None; Wolfgang Berger, None; Christian Grimm, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6081. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jadwiga Oczos, Barbara Kloeckener-Gruissem, Wolfgang Berger, Christian Grimm; Paraoxonase-1 (PON1) in retinal physiology and pathophysiology. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6081. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Paraoxonase-1 (PON1) has anti-oxidant activity and is thought to prevent or reduce oxidation of low density lipoprotein (LDL). Recently, we have shown association between age-related macular degeneration (AMD) and single nucleotide polymorphisms in the upstream regulatory region of the PON1 gene. Little information on expression and the role of PON1 in the retinal physiology is available. The aim of our work was to study Pon1 expression pattern in the mouse retina and in primary mouse retinal pigment epithelial (mRPE) cells. Another objective was to determine the role of PON1 in retinal physiology by comparing Pon1 knockout (Pon1-/-) with control mice.

Methods: Laser Capture Microscopy (LCM) was used to obtain tissue from different retinal layers (RPE, ONL, INL, GCL). Primary mRPE cells were isolated from adult mice and cultured in vitro. Gene expression was assessed by PCR and RT-PCR. Pon1-/- and control mice were exposed to 15000 lux of white light for 2 hours to induce severe photoreceptor degeneration. Retinal morphology was evaluated by light microscopy.

Results: Pon1 was strongly expressed in RPE, which has been demonstrated in tissue isolated by LCM and in freshly isolated mouse RPE. Pon1 expression was downregulated in primary mRPE cells after 1 day in culture and could not be restored by compounds known to up-regulate Pon1 expression. No phenotype was observed in Pon1-/- mice up to 13 months of age. Pon1-/- and control mice were similarly susceptible to light induced photoreceptor degeneration.

Conclusions: Pon1 is strongly expressed in the RPE of the mouse eye in vivo, but its expression is quickly down-regulated in primary mRPE cells in culture. Absence of PON1 did not induce an obvious phenotype suggesting that PON1 may not be required for the development and maintenance of a normally layered retina. A potential involvement of PON1 in the internalization of LDL and/or oxidized LDL into RPE cells will be tested in vivo.

Keywords: 701 retinal pigment epithelium • 634 oxidation/oxidative or free radical damage  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×